The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy

Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature

136

Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, Harbeck N, Span PN, Hicks DG, Crowe J, Tubbs RR, Budd GT, Lyons J, Sweep FC, Schmitt M, Schittulli F, Golouh R, Talantov D, Wang Y, Foekens JA